title: [Indication and meaning of hepatic resection for metastatic liver tumors from gastric cancer].
abstract: To clarify the efficacy and indication of hepatectomy in gastric cancer metastasis to the liver, we studied 26 liver metastases patients undergoing hepatectomy. The cumulative 5-year survival rations were 25.3%. A survival analysis showed that prognoses of patients n(-) or T2 group were statistically better than other group. Three patients underwent a repeat liver resection from gastric metastasis and survived for about thirty months. There was an example using chemotherapy which made a liver tumor removal operation possible to the patient who had multiple liver metastases. In conclusion, liver resection is a beneficial option and multimodal therapy including a repeat liver resection and systemic chemotherapy, may be important for improving the prognosis of patients with liver metastases from gastric cancer.
authors.affiliation: Dept. of Surgery, Tokyo Metropolitan Bokutoh Hospital.
authors.forename: Kazumasa
authors.initials: K
authors.lastname: Noda
authors.forename: Nobutaka
authors.initials: N
authors.lastname: Umekita
authors.forename: Yukako
authors.initials: Y
authors.lastname: Shiba
authors.forename: Takao
authors.initials: T
authors.lastname: Ookubo
authors.forename: Satoshi
authors.initials: S
authors.lastname: Inoue
authors.forename: Masatsugu
authors.initials: M
authors.lastname: Kitamura
mesh_terms: D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D005260:Female; D006498:Hepatectomy; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary* / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D013274:Stomach Neoplasms / Q000401:mortality / Q000473:pathology*